Sarcosinates as fluazifop-butyl adjuvants and activators

A - Human Necessities – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A01N 43/40 (2006.01)

Patent

CA 2223619

An adjuvant for Fluazifop-butyl, and preferably Fluazifop-P-butyl, having increased activity, lower irritancy and lower toxicity than conventional adjuvants. The adjuvant is C8 to C22 sarcosinate or sarcosinate salt, such as sodium cocoyl sarcosinate, sodium lauroyl sarcosinate, or combinations thereof, which is combined with Fluazifop-P-butyl and provides more effective activity.

Adjuvant de Fluazifop-butyle, et de préférence de Fluazifop-P-butyle, présentant une meilleure activité, une faible propriété irritante et une faible toxicité par rapport aux adjuvants traditionnels. L'adjuvant est un sarcosinate en C8 à C22 ou un sel de sarcosinate, tel que le sarcosinate cocoyle de sodium, le sarcosinate lauroyle de sodium, ou des combinaisons de ceux-ci, qui est combiné à Fluazifop-P-butyle et confère une activité plus efficace.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Sarcosinates as fluazifop-butyl adjuvants and activators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sarcosinates as fluazifop-butyl adjuvants and activators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sarcosinates as fluazifop-butyl adjuvants and activators will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1929598

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.